Home
Samrat Pharmachem Ltd EPS

Samrat Pharmachem Ltd
NSE: SAMRATPHARMA
EPS
Key Highlights
- The Earning per Share of Samrat Pharmachem Ltd is ₹ 23.02 as of 03 Jul 25 .
- The earning per share of Samrat Pharmachem Ltd changed from ₹ 1.98 to ₹ -1.29 over 8 quarters. This represents a CAGR of NaN% .
Historical Earning per Share of Samrat Pharmachem Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Samrat Pharmachem Ltd
Company Fundamentals for Samrat Pharmachem Ltd
Market Cap
108 Cr
EPS
23.0
P/E Ratio (TTM)
15.2
P/B Ratio (TTM)
1.5
Day’s High
357.95
Day’s Low
345.0
DTE
0.1
ROE
9.9
52 Week High
646.0
52 Week Low
302.05
ROCE
12.9
Market Price of Samrat Pharmachem Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
03 Jul 2025 | 349.95 |
02 Jul 2025 | 355.45 |
01 Jul 2025 | 352.8 |
30 Jun 2025 | 358.85 |
27 Jun 2025 | 361.05 |
26 Jun 2025 | 344.85 |
25 Jun 2025 | 342.45 |
24 Jun 2025 | 339.95 |
23 Jun 2025 | 343.95 |
20 Jun 2025 | 341.3 |
BlinkX Score for Samrat Pharmachem Ltd
Asset Value vs Market Value of Samrat Pharmachem Ltd
Market Value
₹ 108
Asset Value
Value addition
0.0 X
₹ 103
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Samrat Pharmachem Ltd | 108.12 | 23.02 |
Sun Pharmaceutical Industries Ltd | 402788 | 47.81 |
Divis Laboratories Ltd | 182283 | 82.53 |
Cipla Ltd | 121847 | 63.71 |
Torrent Pharmaceuticals Ltd | 112909 | 56.97 |
Dr Reddys Laboratories Ltd | 107932 | 66.48 |
Company | |
---|---|
Samrat Pharmachem Ltd | 108.12 |
Sun Pharmaceutical Industries Ltd | 402788 |
Divis Laboratories Ltd | 182283 |
Cipla Ltd | 121847 |
Torrent Pharmaceuticals Ltd | 112909 |
Dr Reddys Laboratories Ltd | 107932 |
Historical Market Cap of Samrat Pharmachem Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Samrat Pharmachem Ltd
Historical Revenue of Samrat Pharmachem Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Samrat Pharmachem Ltd
Historical EBITDA of Samrat Pharmachem Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Samrat Pharmachem Ltd
Historical Net Profit of Samrat Pharmachem Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Samrat Pharmachem Ltd
Dividend Payout Over Time
Samrat Pharmachem Ltd News Hub
Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter
Net profit of Samrat Pharmachem rose 239.34% to Rs 2.07 crore in the quarter ended June 2024 as agai
Read more
13 Aug 24
Samrat Pharmachem announces board meeting date
Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024.
Read more
28 Sept 24
Samrat Pharmachem to declare Quarterly Result
Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2025.
Read more
31 Dec 24
Samrat Pharmachem reports standalone net profit of Rs 2.66 crore in the September 2024 quarter
Net profit of Samrat Pharmachem reported to Rs 2.66 crore in the quarter ended September 2024 as aga
Read more
15 Nov 24